Back to results
US 9,428,505 B2Granted
Hydantoin derivative
AssigneeChugai Seiyaku Kabushiki Kaisha
InventorsYoshikazu Nishimura, Toru Esaki, Tatsuya Tamura
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds represented by formula (1) below and pharmacologically acceptable salts thereof: wherein R1, R2, R3, and R4 are as defined in the claims.
Claims4
A compound or pharmacologically acceptable salt or a hydrate or a solvate thereof, wherein the compound is 1-(3,5-dimethyl-4-(2-((4-oxo-2-(4-(trifluoromethoxy)phenyl)-1,3,8-triazaspiro[4.5]deca-1-en-8-yl)sulfonyl)ethyl)phenyl)-5,5-dimethylimidazolidine-2,4-dione.
Dependencies are inferred from the claim text.